IPCA Laboratories

IPCA Laboratories CROIC

The Cash Return on Invested Capital (CROIC) of IPCA Laboratories (IPCALAB.NS) as of Oct 30, 2026 is 5.95 %. In the previous year, Cash Return on Invested Capital (CROIC) was 6.79 % — a change of -12.42% (lower).

CROIC

5.95 %

YoY

-12.42%

Last updated:

Cash Return on Invested Capital (CROIC) of IPCA Laboratories is 2026 5.95 % . Cash Return on Invested Capital (CROIC) of IPCA Laboratories was 2025 6.79 % . It decreases by -12.42% lower compared to the previous year.

The IPCA Laboratories CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
9.23 INR
Jan 1, 2020
6.51 INR
Jan 1, 2021
14.88 INR
Jan 1, 2022
6.04 INR
Jan 1, 2023
4.34 INR
Jan 1, 2024
8.12 INR
Jan 1, 2025
6.79 INR
Jan 1, 2026
5.95 INR
The IPCA Laboratories CROIC history
YEARCROICYoY
5.95 %-12.42%
6.79 %-16.37%
8.12 %+87.04%
4.34 %-28.18%
6.04 %-59.39%
14.88 %+128.50%
6.51 %-29.42%
9.23 %+42.74%
6.47 %+32.53%
4.88 %-69.05%
15.76 %-375.66%
-5.72 %-214.46%
5.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IPCA Laboratories Stock analysis

What does IPCA Laboratories do? Ipca Laboratories Ltd. generates revenue through the manufacturing and marketing of over 350 pharmaceutical formulations and approximately 80 active pharmaceutical ingredients (APIs), including Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts, and Propranolol. The company sells its branded products such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, and Venpower in more than 100 countries globally. Its subsidiaries, Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd, and Tonira Exports Limited, support the distribution and sales of these products across international markets. The company's primary customers are healthcare providers, hospitals, and pharmacies in over 100 countries, purchasing both generic APIs and branded formulations. Manufacturing units in India produce APIs and formulations, with the firm's subsidiaries facilitating global market access. The therapeutic segments covered by its products include cardiovascular, antimalarial, and gastrointestinal treatments, among others, driven by the demand for cost-effective pharmaceutical solutions. IPCA Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IPCA Laboratories stock

Cash Return on Invested Capital (CROIC) of IPCA Laboratories is 5.95 % in 2026.

Cash Return on Invested Capital (CROIC) of IPCA Laboratories changed from 6.79 % to 5.95 %, representing a -12.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) IPCA Laboratories since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s IPCA Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — IPCA Laboratories

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — IPCA Laboratories